A randomised clinical trial on the effectiveness of Emla and Rapydan for prevention of vena punction-induced pain in children.

Phase 4

Completed

• Conditions: Pijnbeleving; Pain perception/ discomfort

• Registration Number: NL-OMON35993
• Lead Sponsor: Isala Klinieken

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 200

Inclusion Criteria

Age 3 - 18

Exclusion Criteria

Allergy for the contents of the plaster

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Pain score on pain face-scale. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Redness, Swelling, Access to the vein.</p><br>